Basics Spyre Therapeutics, Inc. IPO Date: April 4, 2016 Sector: Healthcare Industry: Biotech Market Cap: $929.44M Activated in VL: True Average Daily Range Avg Daily Range: $0.90 | 3.52% Avg Daily Range (30 D): $0.36 | 2.44% Avg Daily Range (90 D): $0.56 | 3.31% Institutional Daily Volume Avg Daily Volume: .42M Avg Daily Volume (30 D): .33M Avg Daily Volume (90 D): .49M Trade Size Avg Trade Size (Sh.): 65 Avg Trade Size (Sh.) (30 D): 54 Avg Trade Size (Sh.) (90 D): 59 Institutional Trades Total Inst.Trades: 706 Avg Inst. Trade: $2.03M Avg Inst. Trade (30 D): $1.53M Avg Inst. Trade (90 D): $1.52M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.56M Avg Closing Trade (30 D): $1.68M Avg Closing Trade (90 D): $1.79M Avg Closing Volume: 105.91K     News Mar 5, 2024 @ 3:56 PM NIO Reports Upbeat Earnings, Joins Dave, V2X, Risk... Source: Avi Kapoor Mar 4, 2024 @ 1:50 PM Here's What Could Help Spyre Therapeutics (SYRE) M... Source: Zacks Equity Research Feb 6, 2024 @ 2:55 PM Here's Why Spyre Therapeutics (SYRE) Could be Grea... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.36 $-.86 Diluted EPS $-1.36 $-.86 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -44.77M $ -69.03M $ -38.84M Operating Income / Loss $ -53.57M $ -55.39M $ -44.15M Cost of Revenue $ $ $ Net Cash Flow $ -40.93M $ 26.12M $ -182.41M PE Ratio     Splits Sep 08, 2023:   1:25